NEWAI CHEMICAL INDUSTRIAL CO., LTD.

Newai Chemical Industrial Co., Ltd., officially reorganized from former Newai New Drug Industrial
Co., Ltd. in 1983, is a cGMP approval pharmaceutical manufacturer based in Taiwan. We manufacture and market more than 200 products to customers. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, transdermals, controlled- release, and liquids products. To access the future development in the health care field, in addition to pharmaceutical business, we work to develop cutting- edge health products and enhance
our innovation. In biopharmaceutical section, our aim is to develop high-entry-barrier products and herbal treatments to deliver medicines that improve the lives of patients. As we look to the future, we will continue to focus on innovation, high-standard quality controlling, and to maintain a lean and efficient operation with solid growth prospects to make the commitment of bringing health and good life to people.


	What is taken from the people is what is used in the interest of the people.


	With continuous innovation, we advance health and quality of life in human healthcare.

Today, Newai is conducting research and development into innovative products to enhance current product pipelines.

In an increasingly competitive in-licensing environment, speed is a key advantage. To accelerate our step, new products are sourced both from own research and from external partners such as science institutions and Contract Research Organizations (CRO). Newai’s R&D is also attentive to the future plan in delivering new therapeutics to chronic disease patients who suffer from diabetes and cardiovascular disease.